New strain of Carnobacterium maltaromaticum and its uses
The new Carnobacterium maltaromaticum CNCM 1-5804 strain, with a unique inhibition mechanism, addresses the persistence of Listeria monocytogenes by inducing rapid decline, enhancing biopreservation efficacy in food products.
Patent Information
- Application Number
- FR2022014072
- Authority / Receiving Office
- FR · FR
- Patent Type
- Patents
- Current Assignee / Owner
- Filing Date
- 2022-12-21
- Publication Date
- 2024-11-22
- Estimated Expiration
- Not applicable · inactive patent
AI Technical Summary
Existing biopreservative cultures, such as lactic acid bacteria, fail to provide optimal and lasting protection against Listeria monocytogenes in food products, allowing the pathogen to persist and posing health and economic risks.
A new strain of Carnobacterium maltaromaticum CNCM 1-5804, which inhibits Listeria monocytogenes without forming an inhibition halo, is combined with other strains to induce a rapid decline in pathogen levels, offering a novel mechanism of action.
The new strain CNCM 1-5804, when used alone or in combination with other strains, effectively reduces Listeria monocytogenes populations in food products, extending shelf life and ensuring safety.
Smart Images

Figure 00000013_0000 
Figure 00000013_0001 
Figure 00000013_0002
Abstract
Description
Title of the invention: New strain of Carnobacterium malta-romaticum and its uses
[0001] The invention relates to a specific strain of Carnobacterium maltaromaticum, a bacterial preparation comprising at least said strain and their use in the preparation of a food product.
[0002] The presence of pathogenic bacteria in food is a major public health issue. In the cheese industry, the potential presence of Listeria monocytogenes is a constant concern. The presence of this pathogen in processed dairy products regularly leads to incidents that jeopardize consumer health and the economic stability of industry stakeholders. For example, the highly publicized recall of several batches of cheese contaminated with L. monocytogenes in December 2015 is a case in point. Consequently, industry stakeholders are actively seeking solutions to better control the Listeria risk.
[0003] Some companies specializing in the production and marketing of microorganisms offer biopreservative / bioprotective microbial cultures with anti-Listeria properties. For example, it is known that certain strains of Lactobacillus plantarum possess anti-Listeria activity. One strain of L. plantarum is notably marketed under the brand name HOLDBAC® as a biopreservation / bioprotection starter culture.
[0004] However, despite the use of these biopreservative cultures, the presence of L. monocytogenes persists, presumably because the proposed biopreservative cultures are classic lactic acid bacteria which do not allow for optimal and lasting protection throughout the life of the food product.
[0005] The anti-Listeria activity of lactic acid bacteria strains of the species Carnobacterium maltaromaticum has also been described in the prior art. For example, the Inventors previously identified the C. maltaromaticum strains CNCM 1-5242 and CNCM 1-5243 as having remarkable inhibitory properties against L. monocytogenes in a cheese matrix (FR 3102489 Bl). However, even though these strains effectively inhibit the growth of L. monocytogenes, they do not induce its decline.
[0006] There is therefore a real need to have means to reduce the presence, and in particular to induce the decrease, of L. monocytogenes in food products.
[0007] In this context, the Inventors identified a new strain of C. malta- *C. maltaromaticum* possesses particularly useful biopreservation properties. Unexpectedly, the presence of this strain leads to a rapid decrease in the quantity of the pathogen, indicating that this strain inhibits the *L. monocytogenes* population. Furthermore, unlike previously identified *C. maltaromaticum* strains, this new strain inhibits *L. monocytogenes* without forming an inhibition zone on agar plates in a competition test, suggesting a novel mechanism of action.
[0008] Also, one aspect of the invention relates to the strain C. maltaromaticum CNCM I-5804.
[0009] This isolated strain was deposited with the National Collection of Microorganism Cultures (CNCM) (Institut Pasteur, 25 rue du Docteur Roux, 75724 PARIS, France) on January 6, 2022 under the number CNCM 1-5804, in accordance with the Treaty of Budapest.
[0010] In co-culture with the luminescent L. monocytogenes strain EGDelux, the CNCM 1-5804 strain induces a extinction of luminescence, which demonstrates its ability to inhibit L. monocytogenes.
[0011] In a classic competition test on agar medium with L. monocytogenes, the CNCM 1-5804 strain does not generate an inhibition halo, which indicates a different and complementary L. monocytogenes inhibition mechanism to that of the C. maltaromaticum strains already identified.
[0012] Furthermore, the combination of CNCM 1-5804 with at least one other strain of C. maltaromaticum induces a much more effective inhibition of L. monocytogenes than with the strains of C. maltaromaticum used alone.
[0013] This synergistic effect of the CNCM 1-5804 strain with other strains of C. maltaromaticum reveals a promising potential for reducing the amount of L. monocytogenes in a cheese-type food.
[0014] Another aspect of the invention relates to a bacterial preparation comprising the CNCM 1-5804 strain.
[0015] The term "bacterial preparation" means a composition conditioned for the growth of Camobacterium maltaromaticum, said composition comprising a viable strain of C. maltaromaticum and essential components for bacterial growth, such as a source of carbon and energy, a source of potassium and phosphorus, a source of calcium, a source of magnesium, lipids, proteins or amino acids.
[0016] Said bacterial preparation may comprise a culture medium or an extract of culture medium. Said medium may be TSB-YE medium (Tryptone Soy Broth-Yeast Extract).
[0017] Said culture medium may be a synthetic medium. By synthetic medium, we mean According to the present invention, this means a medium into which individual components are introduced, characterized and subjected to rigorous quantitative and qualitative control.
[0018] Said culture medium may also be a natural medium. By natural medium, the present invention means a medium that contains one or more natural compounds in its composition. Said natural medium may be milk (whole, semi-skimmed or skimmed), in particular raw, heat-treated, pasteurized or UHT (Ultra High Temperature) milk.
[0019] Said bacterial preparation may be in liquid or solid form.
[0020] In one embodiment of the invention, the concentration of C. maltaromaticum, in particular of strain CNCM 1-5804, in said bacterial preparation of the invention may be from 102 CFU.mL 1 to 1011 CFU.mL *, in particular from 105 CFU.mL 1 to 107 CFU.mL *, more particularly from at least 105 CFU.mL *, or from at least 106 CFU.mL *, or from at least 107 CFU.mL *, relative to the total volume of the bacterial preparation.
[0021] In one embodiment of the invention, the concentration of C. maltaromaticum, in particular of strain CNCM 1-5804, in said bacterial preparation of the invention may be 102 CFU.mL1, 103 CFU.mL1, 104 CFU.mL1, 105 CFU.mL1, 106 CFU.mL1, 107 CFU.mL1, 108 CFU.mL1, 109 CFU.mL1, 1010 CFU.mL1 or 1011 CFU.mL1, relative to the total volume of the bacterial preparation.
[0022] In another embodiment of the invention, said bacterial preparation contains an amount of C. maltaromaticum, in particular of strain CNCM 1-5804, of 102 CFU.g 1 to 1011 CFU.g *, in particular of 105 CFU.g 1 to 107 CFU.g *, of at least 105 CFU.g *, or of at least 106 CFU.g *, or of at least 107 CFU.g *, relative to the total weight of the bacterial preparation.
[0023] In one embodiment of the invention, the concentration of C. maltaromaticum, in particular of strain CNCM 1-5804, in said bacterial preparation of the invention may be 102 CFU.g1, 103 CFU.g1, 104 CFU.g1, 105 CFU.g*, WCU.g1, 107 CFU.g1, 108 CFU.g1, 109 CFU.g1, 1010 CFU.g1 or 1011 CFU.g relative to the total weight of the bacterial preparation.
[0024] In a particular embodiment, said bacterial preparation is a liquid concentrate, a frozen concentrate or a lyophilized product.
[0025] The term "concentrate" means a liquid containing a quantity of bacteria greater than 105 CFU.mL *, in particular greater than 1010 CFU.mL *, especially greater than 1011 CFU.mL *, relative to the total volume of the concentrate.
[0026] The concentrate can be obtained by any conventional method, for example by centrifugation or by microfiltration of a culture of C. maltaromaticum after suitable incubation.
[0027] The term "lyophilized" means the product obtained after lyophilization of a C. culture. maltaromaticum after the appropriate incubation.
[0028] "Adapted incubation" means incubation according to a conventional method to obtain an initial population of C. maltaromaticum close to 107 CFU.mL*, relative to the total volume of the incubation.
[0029] By way of example, the incubation of C. maltaromaticum can be carried out at 30°C for 48 hours in pasteurized whole milk.
[0030] In a particular embodiment, said bacterial preparation is a concentrate, optionally frozen, comprising pasteurized whole milk and at least 107 CFU.mL 1 of C. maltaromaticum CNCM 1-5804, relative to the total volume of the bacterial preparation.
[0031] In a particular embodiment, said bacterial preparation is a concentrate, optionally frozen, comprising UHT whole milk and at least 107 CFU.mL 1 of C. maltaromaticum CNCM 1-5804, relative to the total volume of the bacterial preparation.
[0032] In one embodiment of the invention, said bacterial preparation may further comprise at least one lactic acid bacteria and / or at least one ripening bacteria.
[0033] According to one embodiment of the invention, said bacterial preparation is a protective culture of C. maltaromaticum.
[0034] A "protective culture of Camobacterium maltaromaticum" means a composition containing live C. maltaromaticum bacteria which can be added to food products to inhibit the growth of pathogenic or toxic microorganisms for humans or animals present in said food products, in order to reduce the risk of contamination of food products by these pathogenic or toxic microorganisms.
[0035] For the purposes of the present invention, said pathogenic or toxic microorganism is a bacterium of the genus Listeria, in particular Listeria monocytogenes.
[0036] Said protective culture may be in the form of a liquid concentrate or in the form of a lyophilized powder.
[0037] According to one embodiment of the invention, the bacterial preparation further comprises at least one strain of C. maltaromaticum different from CNCM 1-5804.
[0038] According to one embodiment of the invention, the bacterial preparation further comprises at least one strain of C. maltaromaticum exhibiting an inhibition halo in competition test on agar medium with L. monocytogenes.
[0039] The inhibition test in agar medium can be easily carried out by a person skilled in the art according to the protocol described in the examples.
[0040] According to one embodiment of the invention, the bacterial preparation further comprises at least one strain of C. maltaromaticum selected from the CNCM I- strains 5242 and CNCM 1-5243.
[0041] These two isolated strains were deposited with the National Collection of Microorganism Cultures (CNCM) (Institut Pasteur, 25 rue du Docteur Roux, 75724 PARIS, France) on September 26, 2017 respectively under the numbers CNCM 1-5242 and CNCM 1-5243, in accordance with the Budapest Treaty.
[0042] According to one embodiment of the invention, the bacterial preparation further comprises the CNCM 1-5242 strain.
[0043] According to one embodiment of the invention, the bacterial preparation further comprises the CNCM 1-5243 strain.
[0044] According to one embodiment of the invention, the bacterial preparation further comprises the CNCM 1-5242 strain and the CNCM 1-5243 strain.
[0045] Another aspect of the invention relates to the use of the C. maltaromaticum CNCM 1-5804 strain, of a bacterial preparation described above or of a protective culture described above, in the preparation of a food product.
[0046] More specifically, the CNCM 1-5804 strain, the bacterial preparation described above or the protective culture described above is used to inhibit the growth of bacteria of the genus Listeria, in particular L. monocytogenes, in a food product.
[0047] According to the invention, the expression "Listeria inhibition" (or "Listeria growth inhibition") means the reduction of growth, the blocking of growth or the decrease of bacteria of the genus Listeria.
[0048] Said protective culture of the invention can be used in the production of fermented or unfermented dairy products, in particular in the production of cheeses or fermented milks.
[0049] In a particular embodiment, said food product is a fermented dairy product, in particular cheeses, such as soft cheeses, cooked or uncooked pressed cheeses, fresh cheeses, goat cheeses, sheep cheeses, or fermented milks. Said protective culture of the invention can also be used in the production of other dairy products, such as cream, ice cream, butter, or by-products derived from milk, such as whey, casein, or other prepared food products containing milk or milk constituents as an ingredient.
[0050] Said protective culture of the invention can also be used in the production of beverages, for example fruit juices, beverages obtained with mixtures of milk and fruit juices, soy milk, oat milk, rice milk or fermented vegetable products.
[0051] Said protective culture of the invention can also be used in the industrial production of cured meat and charcuterie products.
[0052] The use of the protective culture of the invention during the manufacture of food products allows the inhibition of Listeria bacteria which remain in a food product in small quantities and extends the storage period of said food product.
[0053] The protective culture of C. maltaromaticum according to the present invention is added to food products according to the type of product.
[0054] For fermented dairy products, such as cheeses or fermented milks, the protective culture is added before or at the same time as the lactic ferments or after their addition.
[0055] For other food products, the protective culture can be added at the beginning of the production line, during the production line or at the end of the production line and in particular before the packaging of the food product.
[0056] By way of example, the protective culture of C. maltaromaticum according to the present invention is added to a liquid food product to achieve a level of 102 CFU.mL 1 to 1011 CFU.mL *, in particular from 105 CFU.mL-1 to 107 CFU.mL *, more particularly of at least 106 CFU.mL *, in particular between 106 CFU.mL 1 and 107 CFU.mL *, relative to the total volume of said liquid food product; or added to a solid food product to achieve a level of 102 CFU.g 1 to 1011 CFU.g in particular from 105 CFU.g 1 to 107 CFU.g *, of at least 105 CFU. g1, or at least 106UFC.g1, or at least 107 UFC.g*, in relation to the total weight of said solid food product, during the storage period of said food product.
[0057] Another aspect of the invention relates to a method for preparing a cheese, in particular a soft cheese or an uncooked pressed cheese, using the CNCM 1-5804 strain or a bacterial preparation containing said strain.
[0058] Said process comprises:
[0059] - inoculation with the CNCM 1-5804 strain or with a bacterial preparation described above including at least the CNCM 1-5804 strain in the milk or during milk processing.
[0060] According to the method of the invention, inoculation with the CNCM 1-5804 strain can be carried out in milk, whey, brine, or directly onto the cheese curd. According to the method of the invention, when inoculation is carried out on the cheese curd, it can be done by spraying or aerating a liquid preparation comprising the CNCM 1-5804 strain onto the cheese curd.
[0061] "Inoculation during the transformation of milk" in cheesemaking means inoculation during storage, pre-maturation, coagulation, draining, molding, pressing, salting, ripening, care or washing.
[0062] According to the method of the invention, when the seeding is carried out in the milk, Inoculation can be carried out with or without cold maturation of the milk.
[0063] Furthermore, the inoculation in milk with the CNCM 1-5804 strain can be carried out before or simultaneously with the inoculation of lactic ferments.
[0064] In another embodiment, the inoculation of the CNCM 1-5804 strain is carried out from 0 to 8 hours before that of the lactic ferments.
[0065] The milk used in said process may be whole or processed, raw or pasteurized, or heat-treated. "Pasteurized whole milk" means whole milk that has undergone heat treatment, for example at 71.5°C for 15 seconds, then rapidly cooled to 4°C.
[0066] In one embodiment of the process, the milk is inoculated with the CNCM 1-5804 strain at a rate of 102 CFU.mL 1 to 1011 CFU.mL *, in particular from 106 CFU.mL 1 to 107 CFU.mL *, relative to the volume of the milk.
[0067] In one embodiment, inoculation with the CNCM 1-5804 strain is carried out jointly with inoculation of at least one bacterium other than CNCM 1-5804, preferably a lactic acid bacterium.
[0068] In one embodiment, the inoculation is carried out by a bacterial preparation comprising the CNCM 1-5804 strain and at least one bacterium different from CNCM 1-5804, preferably a lactic acid bacterium.
[0069] In one embodiment, the bacterium other than CNCM 1-5804 is a proteobacterium.
[0070] In one embodiment, the lactic acid bacterium other than CNCM 1-5804 is chosen from the group comprising the genera Carnobacterium, Enterococcus, Lacto-bacillus, Lactococcus and Staphylococcus.
[0071] In a preferred embodiment, inoculation with strain CNCM 1-5804 is carried out jointly with inoculation with at least one strain of C. malta-romaticum different from CNCM 1-5804, in particular strain CNCM 1-5242 and / or strain CNCM 1-5243.
[0072] In a preferred embodiment, the inoculation is carried out by a bacterial preparation comprising the CNCM 1-5804 strain and at least one C. maltaromaticum strain different from CNCM 1-5804, in particular the CNCM 1-5242 strain and / or the CNCM 1-5243 strain.
[0073] In one embodiment, the inoculated milk is incubated at a temperature of at least 2°C, preferably at least 30°C.
[0074] In one embodiment, the inoculated milk is incubated at a temperature of 2°C to 65°C.
[0075] In one embodiment, the inoculated milk is incubated at a temperature of at least 2°C, 3°C, 4°C, 5°C, 6°C, 7°C, 8°C, 9°C, 10°C, 11°C, 12°C, 13°C, 14°C, 15°C, 20°C, 25°C, 30°C, 35°C, 40°C, 45°C, 50°C, 55°C, 60°C or 65°C.
[0076] In one aspect, the invention therefore also relates to food products, such as those described above, comprising the CNCM 1-5804 strain.
[0077] Another aspect of the invention relates to a method for reducing microbial contamination during the manufacturing process of a fermented dairy product comprising the addition of an inhibitory amount of the CNCM 1-5804 strain or of a bacterial preparation containing the CNCM 1-5804 strain.
[0078] The present invention also proposes a method for reducing contamination by Listeria bacteria during the manufacturing process of a fermented dairy product, characterized in that it comprises the addition of an amount of 10² CFU.mL¹ to 10¹¹ CFU.mL*, in particular 10⁶ to 10⁷ CFU.mL*, relative to the volume of the dairy product, of the CNCM 1-5804 strain or of a bacterial preparation comprising the CNCM 1-5804 strain.
[0079] The attached figures illustrate the invention:
[0080] [Fig. 1] Demonstration of different types of inhibition mechanisms of L. monocytogenes by C. maltaromaticum strains: (A), C. maltaromaticum CNCM I-5804; (B), C. maltaromaticum CNCM 1-5242
[0081] [Fig.2] Growth of Listeria monocytogenes in pre-cheese matrices inoculated with Camobacterium maltaromaticum CNCM 1-5804 and CNCM 1-5242 strains alone or in mixture: (A), at 12°C; (B), at 30°C.
[0082] The present invention will be described below in more detail and with the aid of one or more examples which in no way limit the invention.
[0083] Example 1 - Inhibition of L. monocytogenes on agar
[0084] Materials and methods
[0085] Preparation of Camobacterium maltaromaticum inocula
[0086] Pre-cultures of Camobacterium maltaromaticum (CNCM 1-5242 and CNCM I-5804) are prepared from aliquots frozen at -80°C. 100 pL of these aliquots are added each to a 15 mL Falcon tube containing 10 mL of TSB-YE, then incubated at 30°C for 24 h.
[0087] Preparation of Listeria monocytogenes inocula
[0088] Five Listeria monocytogenes strains (Scott A, PL1447, CA2165, Lal65, and SN167) are streaked on TSA-YE and incubated for 72 h at 30°C. A liquid culture in 10 mL of TSB-YE is then prepared from one colony of each strain. These cultures are incubated for 24 h at 30°C and then mixed in equal volumes. An OD measurement is used to estimate the concentration using a pre-established ratio. Glycerol 50% is added to the culture mixture to achieve a final concentration of 10%. The glycerolized culture mixture is then aliquoted into 1 mL cryotubes and frozen at -80°C.
[0089] Double-layer growth and inhibition halo
[0090] Petri dishes containing TSA-YE agar medium are inoculated with 1.5 µL of each of the Camobacterium maltaromaticum cultures. The inoculations are carried out in the center of each agar plate. These plates are incubated for 24 h at 30°C.
[0091] On the same day, a pre-culture of the mixture of 5 Listeria monocytogenes strains is carried out in TSB-YE medium at 30°C. After growth, the culture is diluted in supercooled TSA-YE to achieve an OD of approximately 0.01 (i.e., approximately 10⁶ CFU / mL). 15 mL of inoculated liquid agar are carefully poured onto the first agar plates to create a second layer. The plates are incubated at 30°C for 24 h.
[0092] Inhibition results on agar
[0093] The results obtained show that the CNCM 1-5804 strain does not exhibit a halo of inhibition towards the mixture of the 5 Listeria monocytogenes strains, whereas the CNCM 1-5242 strain does exhibit a halo ([Fig. 1]). The same is true for the CNCM 1-5243 strain (results not shown). This suggests that the mechanism of action of the CNCM 1-5804 strain in inhibiting Listeria monocytogenes is different from that of the other two strains.
[0094] Example 2 - Tracking of L. monocytogenes in an actual cheese matrix
[0095] Materials and methods
[0096] Preparation of Camobacterium maltaromaticum inocula
[0097] Pre-cultures of Camobacterium maltaromaticum CNCM 1-5804 and CNCM I-5242 are prepared from aliquots frozen at -80°C. 100 pL of these aliquots are added each to a 15 mL Falcon tube containing 10 mL of TSB-YE, then incubated at 30°C for 24 h.
[0098] 500 pL of pre-culture are taken in order to measure the optical density (OD). This A measurement is used to estimate the concentration of each culture using a pre-established DO / (CFU / mL) ratio. The cultures are then centrifuged at 5000 g for 5 min and the pellets resuspended in 9.5 mL of sterile physiological saline. This operation is repeated a second time to wash the cultures. The washed cultures are then cascade-diluted to 5.0 x 10⁸ CFU / mL.
[0099] Preparation of Listeria monocytogenes inocula
[0100] Five strains of Listeria monocytogenes (Scott A, PL 1447, CA2165, Lal65, and SN167) are streaked on TSA-YE from starter cultures. After incubation for 72 h at 30°C, a liquid culture in 10 mL of TSB-YE is prepared from one colony for each strain. These cultures are incubated for 24 h at 30°C and then mixed after measuring the OD. This measurement allows the concentration to be estimated using a pre-established ratio. Glycerol 50% is added to the culture mixture to achieve a final concentration of 10%. The glycerolized culture mixture is then aliquoted into 1 mL cryotubes, then frozen at -80°C.
[0101] Before use, the aliquot is thawed at room temperature and then centrifuged at 5000 g for 5 minutes. The supernatant is discarded and the pellet is resuspended in the same volume of sterile physiological saline. These steps are repeated. The mixture is then cascade-diluted to a concentration of 5.0 x 10⁵ CFU / mL in sterile physiological saline.
[0102] Preparation of Saint-Nectaire samples
[0103] The cheese samples are prepared from pieces of Saint-Nectaire AOP dairy cheese. For each test, the cheeses belong to the same batch. These cheeses are cut into pieces of approximately 10 g (+ / - 1.5 g) after the rind has been removed. Each piece is placed in an individual screw-cap pillbox. A well is then made in the center of the pieces using a Durham tube.
[0104] The cheese pieces are then inoculated or not with the C. mal-taromaticum strains, according to the following methods: - A negative control cheese, not inoculated - A positive control cheese, not inoculated - A cheese inoculated with 20 pL of C. maltaromaticum CNCM 1-5804 - A cheese inoculated with 20 pL of C. maltaromaticum CNCM 1-5242 - A cheese inoculated with 20 pL of C. maltaromaticum CNCM 1-5804 and 20 pL of C. maltaromaticum CNCM 1-5242
[0105] Half of these cheese pieces are incubated at 30°C and the other half at 12°C for 6 days. After these 6 days, 20 µL of the diluted Listeria monocytogenes mixture are added to all cheeses except the negative controls. The jars containing the cheeses are then reincubated at their respective temperatures. For each temperature, there are as many jars of each treatment as there are counting points.
[0106] Enumeration of Listeria monocytogenes
[0107] At each counting point, one cheese from each treatment was removed from the incubator. Each piece was homogenized in a Stomacher (3 x 3 min) in a bag with a side filter containing 90 mL of sterile sodium citrate. The mixture was cascade-diluted (1 mL of mixture + 9 mL of sodium citrate) to the appropriate dilution. 100 or 200 µL of the dilutions were then spread onto PALCAM selective medium in duplicate. The plates were incubated for 24 to 48 h at 30°C.
[0108] Results: growth of L. monocytogenes in cheese matrix
[0109] The results obtained highlight the inhibitory effect of the CNCM I-5804 strain, used alone or in mixture with the CNCM 1-5242 strain (Figure 2A, Figure 2B). At 12°C, the addition of the CNCM 1-5804 strain alone reduces the quantity of L. monocytogenes by approximately 0.7 log1 in the cheese matrix after 27 days (Figure 2A). At 30°C, the addition of the CNCM 1-5804 strain reduces the quantity of L. monocytogenes by approximately 0.7 log1 in the cheese matrix after 27 days (Figure 2A). At 30°C, the addition of the CNCM 1-5804 strain reduces the quantity of L. monocytogenes by approximately 0.7 log1 in the cheese matrix. of the quantity of L. monocytogenes regardless of the incubation time (Figure 2B): this reduction is very clearly greater than 1 log for all incubation times tested and the quantity of L. monocytogenes counted in the cheese matrix never exceeds 1.5.104 CFU / g.
[0110] Furthermore, a complementary behavior is observed of the two strains of C. maltaromaticum CNCM 1-5804 and CNCM 1-5242, when they are added in a mixture to the cheese matrix: in this case, the reduction of the L. monocytogenes population is very significant and reaches 1.4 log after 27 days of incubation at 12°C, and 2.5 log after 27 days of incubation at 30°C. At 30°C and in the presence of the two strains of C. maltaromaticum, the L. monocytogenes population reaches 1.9 x 10⁵ CFU / g at 6 days of growth, then a phase of continuous decline occurs and allows a final population level of 5.7 x 10² CFU / g to be reached after 27 days, i.e. a level lower than the initial level (8.7 x 10² CFU / g).
Claims
Claims
1. Strain of Camobacterium maltaromaticum deposited under number CNCM 1-5804.
2.
3. Bacterial preparation comprising the strain CNCM 1-5804. Bacterial preparation according to claim 2, said preparation further comprising a lactic ferment and / or a ripening ferment.
4. Bacterial preparation according to claim 2 or 3, characterized in that said preparation is a protective culture of C. maltaromaticum.
5. Bacterial preparation according to any one of claims 2 to 4, characterized in that said preparation further comprises at least one strain of C. maltaromaticum different from CNCM 1-5804.
6. Use of a strain according to claim 1 or a bacterial preparation according to any one of claims 2 to 5 in the preparation of a food product.
7. Use according to claim 6, for inhibiting the growth of bacteria of the genus Listeria in a food product.
8.
9. Food product comprising the CNCM 1-5804 strain. Process for preparing a cheese, said process comprising: - seeding with at least one strain of C. maltaromaticum according to claim 1 or a bacterial preparation according to claims 2 to 5, in milk or during the processing of milk.
10. Method for reducing microbial contamination during the manufacturing process of a fermented dairy product characterized in that it comprises the addition of an amount of 102 CFU.mL 1 to 1011 CFU.mL *, in particular 106 to 107 CFU.mL *, relative to the volume of the dairy product, of C. maltaromaticum according to claim 1 or a bacterial preparation according to claims 2-5.
